- Quarterly
- Annual
- TTM
-
Export .csv
-
Download Image
-
Copy link
-
Embed code
Share URL
Bar Chart preview
Tasly Pharmaceutical Group Co., Ltd Operating Cash Flow is USD 275.91 M for the year ending December 31, 2024, a -23.94% change year over year. Operating cash flow is cash generated from the company’s regular business operations. Tasly Pharmaceutical Group Co., Ltd Operating Cash Flow for the year ending December 31, 2023 was USD 362.78 M, a 9.55% change year over year. Tasly Pharmaceutical Group Co., Ltd Operating Cash Flow for the year ending December 31, 2022 was USD 331.14 M, a -24.89% change year over year. Tasly Pharmaceutical Group Co., Ltd Operating Cash Flow for the year ending December 31, 2021 was USD 440.85 M, a 60.65% change year over year. Tasly Pharmaceutical Group Co., Ltd Operating Cash Flow for the year ending December 31, 2020 was USD 274.41 M, a 13.73% change year over year.
Embed chart view
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max